Insights
Search Results
Client Highlights
6.03.26
Wilson Sonsini Advises Isomorphic Labs on $2.1 Billion Series B Investment Round
On May 12, 2026, Isomorphic Labs, an AI-first drug design and development company, announced it has raised $2.1 billion in Series B funding. The financing round is led by Thrive Capital, and includes participation from existing backers Alphabet and GV alongside new investors MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, significantly expanding Isomorphic Labs’ global capital base. Wilson Sonsini Goodrich & Rosati advised Isomorphic Labs on the transaction.
Client Highlights
5.14.26
Wilson Sonsini Advises Insider One on Acquisition of Bluecore
On May 13, 2026, Insider One, a leading agentic customer engagement platform, announced its acquisition of Bluecore, a leading retail marketing technology platform serving more than 400 U.S. enterprise brands. Terms of the transaction have not been disclosed. Wilson Sonsini Goodrich & Rosati advised Insider One on the transaction.
Client Highlights
2.03.26
Wilson Sonsini Advises Remote on Acquisition of Atlas
On January 20, 2026, Remote, the leading global employment operating system, announced it has completed its acquisition of Atlas, an AI-native expense management solution for global teams. The acquisition provides the foundation for a new category of products from Remote to enable customers to offer more holistic and modern employee experiences to their teams.
News Articles
1.26.26
Betty Rosenbaum Named Among The Lawyer’s 2026 Hot 100
On January 26, 2026, Wilson Sonsini London associate Betty Rosenbaum has been recognized in The Lawyer’s 2026 Hot 100 list, which highlights individuals who have significantly influenced the legal profession over the past year. The list features elite dealmakers, top courtroom strategists, and in-house leaders who have navigated the challenges posted by geopolitical instability, economic uncertainty, and ongoing regulatory changes.
Client Highlights
12.15.25
Wilson Sonsini Advises Nu Quantum on Series A Financing
On December 10, 2025, Nu Quantum, the category creator and leader in distributed quantum computing, announced it has closed its $60 million Series A funding round, with participation from new investors National Grid Partners, Gresham House Ventures and Morpheus Ventures, and continued support from existing investors Amadeus Capital Partners, IQ Capital, Ahren Capital, Cambridge Enterprise Ventures, East Innovate, NSSIF, and Sumitomo (Presidio Ventures). It is the largest financing round ever raised by a pure-play quantum networking company, and the largest quantum Series A in the UK to date. Wilson Sonsini Goodrich & Rosati advised Nu Quantum on the transaction.
Client Highlights
4.07.25
Wilson Sonsini Advises Isomorphic Labs on $600 Million External Funding Round
On March 31, 2025, Isomorphic Labs, an AI-first drug design and development company, announced it has raised $600 million in its first external funding round led by Thrive Capital, with participation from GV, and follow-on capital from existing investor Alphabet. Wilson Sonsini Goodrich & Rosati advised Isomorphic Labs on the transaction.
Client Highlights
11.01.24
Wilson Sonsini Advises Insider on $500 Million Series E Financing
On November 1, 2024, Insider, a leading AI-native omnichannel experience and customer engagement platform, announced a $500 million Series E funding round led by General Atlantic, a leading global growth investor. Wilson Sonsini Goodrich & Rosati advised Insider on the transaction.
Client Highlights
10.07.24
Firm Advises Ahren, OMX Ventures, +ND Capital, and Fine Structures Ventures on Constructive Bio’s $58 Million Series A
On September 24, 2024, Constructive Bio, a pioneering synthetic genomics company, announced that it has secured $58 million in the first close of its Series A financing, bringing the total amount raised by the company to date to $75 million. The round was led by Ahren Innovation Capital, OMX Ventures, and Paladin Capital Group with participation from Fine Structure Ventures, +ND Capital, and Abcam-founder Jonathan Milner. Wilson Sonsini Goodrich & Rosati advised Ahren, OMX Ventures, +ND Capital, and Fine Structures Ventures on the transaction.
Client Advisories
9.23.24
“You Promised What?!” Warranties and Disclosure in the UK and the U.S.
Determining “certainty of asset” is a key element of any investment. When an investor takes a minority position as it does in a typical venture or growth capital investment, the approach to ascertaining certainty differs based on the risk appetite and the alignment of the investor and the portfolio company. This article explores and compares the typical U.S. and UK approaches to warranties and disclosures in venture/growth financing transactions.
Client Highlights
4.02.24
Wilson Sonsini Advises Luminance on $40 Million Series B Financing
On April 2, 2024, Luminance, a Cambridge-based legal-grade AI start-up, announced a $40 million Series B financing round led by March Capital, with participation from National Grid Partners and other existing investors, including Slaughter and May. Wilson Sonsini Goodrich & Rosati advised Luminance on the transaction.
Client Highlights
12.06.23
Wilson Sonsini Advises Pragmatic on $231 Million Series D Financing
On December 6, 2023, Pragmatic Semiconductor, the world leader in manufacturing flexible integrated circuits, announced that it completed a first close of its Series D funding round, securing an investment of $206 million. The company is planning a limited second close for key investors, of which $25 million additional investment is already allocated.